Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03GNI
|
||||
Former ID |
DNC008784
|
||||
Drug Name |
ISOQUINE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Malaria [ICD10:B54] | Phase 1 | [532126] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H22ClN3O
|
||||
Canonical SMILES |
CCN(CC)CC1=C(C=C(C=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O
|
||||
InChI |
1S/C20H22ClN3O/c1-3-24(4-2)13-14-5-7-16(12-20(14)25)23-18-9-10-22-19-11-15(21)6-8-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23)
|
||||
InChIKey |
QGFYFOHMBDMGBZ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [529965] | |
Cytochrome P450 2D6 | Target Info | Inhibitor | [529965] | ||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
WikiPathways | SIDS Susceptibility Pathways | ||||
Hematopoietic Stem Cell Differentiation | |||||
Potassium ChannelsWP702:Metapathway biotransformation | |||||
Tamoxifen metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Vitamin D Receptor Pathway | |||||
Aripiprazole Metabolic Pathway | |||||
Fatty Acid Omega Oxidation | |||||
Codeine and Morphine Metabolism | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.